Howard Capital Management’s Pfizer PFE Stock Holding History

Howard Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.65M	Buy	193,027 +79,931	+71%	+$2.09M	0.06%	113
2026 Q1	$3.18M	Sell	113,096 -64,600	-36%	-$1.72M	0.05%	96
2025 Q4	$4.42M	Buy	177,696 +26,272	+17%	+$663K	0.06%	102
2025 Q3	$3.86M	Buy	151,424 +3,115	+2%	+$76.9K	0.05%	111
2025 Q2	$3.6M	Buy	148,309 +11,445	+8%	+$267K	0.05%	111
2025 Q1	$3.47M	Buy	136,864 +6,932	+5%	+$181K	0.09%	93
2024 Q4	$3.45M	Sell	129,932 -8,104	-6%	-$220K	0.05%	102
2024 Q3	$3.99M	Buy	+138,036	New	+$4.03M	0.07%	88
2018 Q4	–	Sell	-308,533	Closed	-$12.9M	–	49
2018 Q3	$12.9M	Buy	308,533 +138	+0%	+$5.31K	1.24%	18
2018 Q2	$11M	Sell	308,395 -109,474	-26%	-$3.74M	1.2%	26
2018 Q1	$14.1M	Buy	417,869 +188,422	+82%	+$6.48M	1.78%	14
2017 Q4	$7.88M	Buy	+229,447	New	+$7.82M	1.26%	45

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Howard Capital Management's PFE Position: Q2 2026 in Review

Howard Capital Management increased its Pfizer (PFE) stake by 71% in Q2 2026, buying an estimated $2.09M and bringing the position to 193,027 shares worth $4.65M. The position accounts for 0.06% of the portfolio, ranked #113.

Howard Capital Management first reported a position in PFE in Q4 2017 and has held it in 12 quarters since. The position peaked at $14.1M in Q1 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Howard Capital Management held 193,027 shares of Pfizer worth $4.65M as of Q2 2026.
Howard Capital Management bought 79,931 Pfizer shares in Q2 2026, an estimated $2.09M.
Pfizer made up 0.06% of Howard Capital Management's portfolio in Q2 2026, its #113 holding.
Howard Capital Management first reported a position in Pfizer in Q4 2017 and has held it in 12 quarters since.
Howard Capital Management's Pfizer position peaked at $14.1M in Q1 2018.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.